Corrigendum to “Real-World Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Nondiabetic Autosomal-Dominant Polycystic Kidney Disease: Effects on Progression to Dialysis in a TrinetX Cohort”

Mayo Clinic Proceeding: Innovations, Quality & Outcomes Volume 10 (2026) 100709

Chia-Hua Chang, MD; Yuan-Chuan Kuo, MD; Yu-Hsiang Kuan, MD, PhD; Paik-Seong Lim, MD, PhD; Mu-Chi Chung, MD; Ying-Ru Pan; Ci-Wen Luo, PhD; and Tsai-Kun Wu, MD, PhD.

From the Division of Renal Medicine (C-H.C., Y-C.K., PS.L., Y-R.P., T-K.W.) and Department of Medical Research (C-W.L.), Tungs’ Taichung Metro Harbor Hospital, Taichung, Taiwan; Department of Pharmacology, School of Medicine (Y-H.K.) and Department of Pharmacy (Y-H.K.), Chung Shan Medical University Hospital, Taichung, Taiwan; Division of Nephrology, Department of Medicine (M-C.C.) and Taichung Veterans General Hospital (MC.C.), Taichung, Taiwan; Department of Post-Baccalaureate Medicine (T-K.W.), College of Medicine, National Chung Hsing University, Taichung, Taiwan; and Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan (M-.C.).

The authors regret that there is a minor error in the Figure 4 caption. The caption currently reads: FIGURE 4. Forest plot of hazard ratios comparing treatment groups among patients with estimated glomerular filtration rate 15 to 45 and 40 to 90 mL/min/1.73 m². We are amending this to read: FIGURE 4. Forest plot of hazard ratios comparing treatment groups among patients with estimated glomerular filtration rate 15 to 45 and 45 to 90 mL/min/1.73 m². The figure content and the underlying analyses are unaffected; only the caption text is incorrect.

The authors would like to apologize for any inconvenience caused.

______________________________.

DOI of original article: https://doi.org/10.1016/j.mayocpiqo.2026.100709

Tsai-Kun Wu MD, PhD josephwu143@gmail.com